Live Breaking News & Updates on Bladder Cancer Director

Stay updated with breaking news from Bladder cancer director. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

GSRGT 2020: The Need for Perioperative Management Strategies: Role of Clinical Oncologists


GSRGT 2020: The Need for Perioperative Management Strategies: Role of Clinical Oncologists - Chemotherapy
(UroToday.com) The penile cancer session at the Global Society of Rare Genitourinary Tumors (GSRGT) 2020 Virtual Summit included a discussion for the role of chemotherapy in the perioperative management of patients with penile cancer by Dr. Guru Sonpavde from the Dana-Farber Cancer Institute. Dr. Sonpavde notes that surgery alone for patients with locally advanced disease is associated with high-risk of recurrence, both locoregionally and distant, with 5-year overall survival (OS) rates of 0-42%. Particularly bad predictors include bulky inguinal adenopathy of ≥ 4cm, bilateral nodes, pelvic lymphadenopathy (N3 disease), an unresectable primary tumor (T4), and extranodal extension. ....

Dana Farber Cancer Institute , United States , Zachary Klaassen , Michaelb Williams , Suks Minhas , Sijin Wen , Curtisa Pettaway , Andrew Lai , Ambuj Kumar , William Osai , Ali Hajiran , Ahmetm Aydin , Charlesc Peyton , Danai Daliani , Michael Kincaid , European Association Of Urology , Augusta University Medical College Of Georgia , Global Society Of Rare Genitourinary Tumors , Harvard Medicine School , Georgia Cancer Center , National Comprehensive Cancer Network , Global Society , Rare Genitourinary Tumors , Guru Sonpavde , Dana Farber Cancer , European Association ,